CERENOME, INC. (CNSY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 600K 1.2M 1.8M Q4 '16: 1.5M Q1 '17: 591K Q2 '17: 969K Q3 '17: 467K Q4 '17: 662K Q1 '18: 731K Q2 '18: 660K Q3 '18: 858K Q4 '18: 1.4M Q1 '19: 703K Q1 '24: 1.7M Q2 '24: 1.3M Q3 '24: 1.5M Q4 '24: 1.4M Q1 '25: 1.1M Q2 '25: 1.4M Q3 '25: 1.4M Q4 '25: 1.4M Q1 '26: 1M Q2 '26: 411K Q1 '17 Q4 '17 Q3 '18 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-600K 0 600K 1.2M 1.8M Q4 '13: 1.6M Q1 '14: 610K Q2 '14: 169K Q3 '14: 181K Q4 '14: 1.1M Q1 '15: 304K Q2 '15: 318K Q3 '15: 264K Q4 '15: 765K Q1 '16: 766K Q2 '16: 541K Q3 '16: 113K Q4 '16: 521K Q1 '17: -125K Q2 '17: 262K Q3 '17: -20K Q4 '17: 29K Q1 '18: 152K Q2 '18: 30K Q3 '18: 230K Q1 '14 Q4 '14 Q3 '15 Q2 '16 Q1 '17 Q4 '17 Q3 '18

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '21: -3.5M Q4 '21: -3.9M Q1 '22: -3.9M Q2 '22: -5.1M Q3 '22: -5.1M Q4 '22: -5.6M Q1 '23: -4.7M Q2 '23: -1.5M Q3 '23: -3.3M Q4 '23: -3.9M Q1 '24: -3.3M Q2 '24: -3.7M Q3 '24: -3.8M Q4 '24: -3.9M Q1 '25: -3.5M Q2 '25: -1.5M Q3 '25: -4.5M Q4 '25: -5.7M Q1 '26: -7.1M Q2 '26: -9.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q3 '21: -3.7M Q4 '21: -4.2M Q1 '22: -4.1M Q2 '22: -5.3M Q3 '22: -5.2M Q4 '22: -5.7M Q1 '23: -4.8M Q2 '23: -1.5M Q3 '23: -3.2M Q4 '23: -3.8M Q1 '24: -3.3M Q2 '24: -2.9M Q3 '24: -2.9M Q4 '24: -3.9M Q1 '25: -17.4M Q2 '25: 5.2M Q3 '25: -4.4M Q4 '25: -5.7M Q1 '26: -6.9M Q2 '26: -9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -2.3M Q4 '21: -2.6M Q1 '22: -3.9M Q2 '22: -2.6M Q3 '22: -4.2M Q4 '22: -2.2M Q1 '23: -5.8M Q2 '23: -2.8M Q3 '23: -2.4M Q4 '23: -1.9M Q1 '24: -4.5M Q2 '24: -1.1M Q3 '24: -3.7M Q4 '24: -1.2M Q1 '25: -6.2M Q2 '25: -5.8M Q3 '25: -2.5M Q4 '25: -6.3M Q1 '26: -6.2M Q2 '26: -7.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '21: -3.1M Q2 '21: -2.4M Q3 '21: -2.3M Q1 '22: -4.1M Q2 '22: -2.8M Q3 '22: -4.3M Q1 '23: -5.9M Q2 '23: -2.8M Q3 '23: -2.4M Q4 '23: -1.9M Q1 '24: -4.6M Q2 '24: -1.2M Q3 '24: -3.7M Q4 '24: -1.2M Q1 '25: -6.2M Q2 '25: -5.8M Q3 '25: -2.6M Q4 '25: -6.3M Q1 '26: -7.1M Q2 '26: -7.6M Q2 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '15: 9.8M Q3 '15: 10.5M Q2 '16: 14.8M Q3 '16: 20.5M Q2 '21: 11.3M Q3 '21: 13.3M Q1 '22: 21.5M Q2 '22: 1.5M Q3 '22: 1.8M Q1 '23: 2.3M Q2 '23: 2.5M Q3 '23: 3.2M Q1 '24: 4.3M Q2 '24: 10.7M Q3 '24: 7.9M Q1 '25: 582.7K Q2 '25: 8.4M Q3 '25: 107.4M Q1 '26: 6.6M Q2 '26: 6.9M Q3 '15 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-45.00 -30.00 -15.00 0.00 15.00 30.00 45.00 Q2 '20: 20.59 Q3 '20: 20.23 Q4 '20: -1.85 Q1 '21: -1.90 Q2 '21: -1.70 Q3 '21: -1.59 Q4 '21: -1.13 Q1 '22: -0.99 Q2 '22: -4.30 Q3 '22: -6.87 Q4 '22: -8.96 Q1 '23: -10.84 Q2 '23: -7.87 Q3 '23: -6.02 Q4 '23: -4.36 Q1 '24: -3.04 Q2 '24: -3.16 Q3 '24: -2.53 Q4 '24: -2.50 Q1 '25: -31.61 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.